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Barbiturates 
Their applicatiolls to veterinary therapeutics 
I. E. Peterson, '44 
D URING the last decade, a new group 
of drugs, known as the barbiturates, 
has come into prominence in veterinary 
medicine as hypnotics and anesthetics. 
Today we find that these derivatives of 
barbituric acid are used quite extensively 
in human medicine and in the small ani-
mal field of veterinary medicine. The 
therapeutic action of the derivatives of 
this parent barbituric acid molecule, which 
is weakly acid but has no sedative or 
hypnotic effect, has been made possible 
because one or both of the hydrogens on 
the side chains are replaceable. Thus, 
barbital or diethyl barbituric acid was 
obtained by replacing each hydrogen with 
an ethyl radical, forming a derivative 
which did possess hypnotic and sedative 
action. Similarly, by replacing one hydro-
gen with an ethyl radical and the other 
with a phenyl radical, phenyl ethyl bar-
bituric acid or phenobarbital, was ob-
tained. This had twice the potency of bar-
bital, yet possessed no greater toxicity. 
Further chemical research with barbituric 
acid produced pentobarbital or nembutal, 
by substituting an ethyl radical for one 
hydrogen and a methyl-butyl group for 
the other. This drug was not used phar-
macologically or clinically for many years 
after it was first synthesized. An isomer 
of pentobarbital called amy tal, which had 
greater hypnotic effect, more rapid action, 
and faster elimination than pentobarbital, 
was produced by Shonle in 1920. The so-
dium salts of these barbituric acid deriva-
tives were later shown to be more soluble 
and more adapted to intravenous and in-
tramuscular injection, thus giving quicker 
and deeper, but shorter, effects. 
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The barbiturates may be generally clas-
sified as long or short acting, and the two 
groups should not be used interchange-
ably. The choice of drug to be used de-
pends on the type of patient, length of 
time and rapidity of action desired, con-
dition of the patient, and history of pre-
vious medication. The barbiturates are 
destroyed mostly in the liver and are ex-
creted to a certain extent by the kidneys. 
In toxic doses, the respiratory system is 
affected more quickly than is the cardiac 
system, but in animals which have a cir-
culatory disturbance, the barbiturates af-
fect the heart and blood pressure even in 
light doses before the respiratory system 
shows any effects of overdosage. In gen-
eral, the contra indications of the barbitu-
rates are hepatic disease, renal impair-
ment, circulatory disturbances, acidosis, 
anemia, respiratory distress from any 
cause, toxemia, shocks, and previous ad-
ministration of other sedatives, hypnotics, 
or anesthetics in large doses. Especially 
those patients showing toxemia or shock 
should be watched very closely during 
administration of the barbiturates for any 
idiosyncrasy to the drug. The barbiturates 
are not usually considered to be habit 
forming in humans, but a few cases of this 
occurrence have been reported. 
Advantages 
The advantages of barbiturates are 
enumerated as follows: 
1. The degrees of action may be easily 
graded from very slightly sedative to com-
plete anesthesia. 
2. The effect is very prompt, within a 
The Veterinary Student 
few minutes after oral doses and imme-
diately after intravenous. 
3. Full doses cause little effect on other 
functions. 
4. The respiratory system, circulation, 
metabolism, and smooth muscle remain 
almost normal until full toxic doses are 
reached. 
5. Most of them have no serious after-
effects. 
6. They produce no serious local ef-
fects so they may be administered by all 
channels. 
The disadvantages of the barbiturates 
are the following: 
1. The response to the drug is not al-
ways the same. 
2. The hypnotic action is sometimes 
preceded by excitement, which is the rea-
son for using a small dose of morphine in 
dogs before administering the barbitu-
rates. 
3. As anesthetics they are administered 
at a single dose, thus making for error in 
the concentration in the body, and they 
require much safer handling when used 
for general anesthesia than when used as 
basal narcotics. 
4. They require too large dosage and 
are therefore too expensive in large ani-
mal practice. 
Indications 
The barbiturates in general are indi-
cated for the following conditions: 
1. As a sedative in nervous conditions, 
2. As an analgesic in neuritis and pru-
ritis, 
3. To control nausea and vomiting, 
4. As a motor depressant in convulsive 
states as in epilepsy, Glclampsia, and strych-
nine poisoning, 
5. Preliminary to local anesthetics to 
prevent accidents with cocaine and pro-
caine, 
6. As preanesthetic narcotic, and 
7. As anesthetics. 
In poisoning with these drugs, respira-
tory stimulants are used. The following 
drugs have been used as antidotes: picro-
toxin or metrazol with ephedrine, picro-
toxin, metrazol, ephedrine, coramine, 
icoral, strychnine, caffeine, dinitrophenol, 
Spring, 1944 
and benezdrine sulfate. Picrotoxin seems 
to be quite superior due to its lasting ef-
fect but all of them must be given in re-
peated dosage since they are eliminated 
from the body more quickly than the bar-
biturates. These should be supplemented 
by injections of hypertonic dextrose solu-
tion and artificial respiration. The bar-
biturates have been used for euthanasia 
in large doses to small animals and the 
younger large animals. The use for this 
purpose has been limited due to the cost 
compared to that of saturated magnesium 
sulfate solution. The barbiturates produce 
death without violent struggling as is 
seen in many other products used for this 
purpose and thus are quite humane. 
Classification 
The barbiturate drugs fall into two 
general classifications, the short acting 
group and slow acting group. The short 
acting group includes pentothal sodium, 
seconal sodium, pentobarbital sodium, 
amy tal, and sodium amy tal. This group 
produces anesthesia very rapidly but is 
short acting due to the rapid elimination 
of the drug from the body. 
Pentothal sodium, or sodium ethyl thio-
barbituric acid, is one of a series of new 
thiobarbiturates. It is rapidly destroyed 
in the body, and although it is rapid in 
effect the duration of this effect is rela-
tively short. It is an excellent anesthetic 
for minor operations in small animals for 
the effect may be gone in 20 to 30 minutes. 
The solution should be freshly made and 
slowly administered, a careful check be-
ing kept on the dose as injection proceeds. 
When anesthesia is sufficiently advanced, 
injection must cease; when the patient is 
unconscious and respiration is shallow, 
anesthesia is usually present. The onset 
of anesthesia is usually so rapid that the 
normal stages of anesthesia cannot be 0 b-
served during the administration of this 
drug. The dosage varies in different ani-
mals; 7.0 to 11.0 mg. per pound body 
weight injected intravenously with a 
standard dose of 10.0 mg. per pound of 
body weight as an average is recom-
mended. The anesthesia will persist for 
25 to 30 minutes when an average dose of 
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pentothal sodium is injected following the 
administration of 8 to 32 mg. of morphine 
and 0.4 to 0.6 mg. of atropine to dogs. 
Seconal sodium has been used in human 
medicine much more extensively than in 
veterinary medicine. However, it is of 
some value as a hypnotic when given in 
small repeated doses to small animals for 
the period of recovery is much shorter 
than that of the longer acting barbiturates. 
This drug causes less renal disturbance 
than other members of the short acting 
group, thus being indicated in those pa-
tients in which pentobarbital sodium 
would have a detrimental effect on the 
renal system. There are no after effects 
following the administration of this drug. 
It has a large margin of safety in dosage 
but larger doses seem to produce restless-
ness rather than the desired hypnosis. 
This drug is recommended for preanes-
thetic medication in small animals. The 
dosage is usually 48 mg. to cats and small 
dogs. Large doses followed by toxic re-
actions of the drug may be counteracted 
by injection of hypertonic dextrose with 
caffeine and ephedrine. 
Nembutal 
Pentobarbital sodium or nembutal is 
a more slowly acting member of the short 
acting group. This is prepared in the forms 
of pentobarbital sodium and pentobarbital 
calcium. The sodium salt is more readily 
soluble and, thus, probably acts more 
quickly than the calcium salt. There is 
no pharmacological difference in their re-
action, and they may be used interchange-
ably. The sodium salt is hygroscopic and 
cannot be prepared in the tablet form. 
The calcium salt of pentobarbital is not 
hygroscopic and is prepared in the tablet 
form for oral or rectal administration only. 
Pentobarbital sodium is the only salt of 
the two which is prepared in the ampoule 
form for intravenous or intramuscular in-
jection. Solutions to be used for this pur-
pose should only be prepared from the 
sterile anhydrous form which is supplied 
in sterile ampoules. Under no circum-
stances should the pentobarbital sodium 
which is prepared in pulvule form for oral 
administration be used for intravenous or 
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intramuscular inejction. The 5 percent 
weight-volume solution is prepared with 
sterile water in the ampoule for this pur-
pose. Discard any solution of this drug 
which exhibits slight opalescence or hazi-
ness. 
Pentobarbital sodium in preanesthetic 
medication has many advantages similar 
to those of sodium amy tal in which it re-
lieves preoperative apprehension by the 
patient, affords more quiet induction of 
anesthesia, reduces the amount of general 
anesthetic required, and diminishes the 
postoperative nausea and vomiting in small 
animals. In comparison to sodium amy tal 
in preanesthetic medication, only one-half 
the dose need be used to produce the same 
effect and the period of postoperative re-
covery is only about one-half as long as 
that following the use of sodium amy tal. 
Overdosage of either drug will produce 
respiratory distress and postoperative rest-
lessness, so one must caution against use 
of barbiturates in doses sufficient to pro-
duce a deep preanesthetic effect for such 
doses predispose to respiratory embarrass-
ment especially when they are supple-
mented with ether to the point of full 
anesthesia. Respiratory distress may also 
be more often noticed in those cases in 
which morphine and pentobarbital sodium 
were used in conjunction in preanesthetic 
medication, followed by complete ether 
anesthesia. So morphine is commonly used 
alone as a preanesthetic medicament in 
dogs. 
Applications 
Pentobarbital sodium is used in doses 
of 50 to 100 mg. orally for preanesthetic 
medication in cats since morphine is ex-
citing to this animal. If the patient will 
not take the drug by way of the mouth, 
it may be given in the form of an enema 
when mixed with a little water and in-
serted into the rectum. Suppositories of 
pentobarbital calcium in cacao butter base 
seem to give good results in controlling 
the convulsions of chorea and in control-
ling the nausea and vomiting complicat-
ing roentgen therapy. These are most 
successful when administered per rectum 
immediately following x-ray treatment. 
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Pentobarbital sodium is not used to any 
great extent in obstetrics since there are 
limiting factors to the use of barbiturates 
in these cases regardless of the route of 
administration. When used in dosage large 
enough to produce complete analgesia or 
complete anesthesia, this drug is quite apt 
to produce respiratory and vascular de-
pression in the pregnant female and en-
tails great risk of producing narcosis in 
the newborn and intensive resuscitation 
efforts are often necessary with close 
supervision for the first 12 hours after 
administration to the dam. This drug has 
been used to good advantage in the con-
trol of strychnine convulsions. It has 
shown good results in the control of other 
nervous symptoms especially those shown 
in chorea of dogs following canine distem-
per complications of the nervous system. 
Pentobarbital sodium should not be used 
in cases of cardiac pr respiratory disturb-
ance, in case of generalized arteriosclero-
sis or in cases of impaired liver or renal 
function. During the postoperative period 
the patient should be observed closely for 
tendency towards choking. This drug 
should not be used following heavy mor-
phine sulfate medication since both of 
these drugs may produce undesirable re-
spiratory depression. Morphine sulfate is 
used hypodermically in low dosage to con-
trol the postoperative restlessness due to 
pain only. Some patients are much more 
susceptible to the toxic reactions of pento-
barbital sodium than others, and these 
should be observed closely following medi-
cation for toxic symptoms of an idiosyn-
crasy or hypersensitivity to the drug. 
Administration 
Nembutal can be administered by a va-
riety of methods. Under ordinary circum-
stances the therapeutic effects of this drug 
can be obtained by oral administration, 
but there are certain advantages to paren-
teral administration. Nausea, vomiting, 
diarrhea or other factors interfering with 
absorption of the orally administered drug 
may make it desirable to give it by the 
parenteral route. Intramuscular injection 
shows a slower onset and lowered inten-
sity of action of the drug than does intra-
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venous injection but the circulatory and 
respiratory depression are less marked. 
Local reaction is usually slight or absent. 
The intravenous route of administration 
of pentobarbital sodium offers the imme-
diate placing of the patient under the in-
fluence of the hypnotic and is the method 
of choice in emergency conditions. The 
intravenous injection of this drug must 
be made carefully and slowly. The rate of 
injection should not exceed 1 cc. per min-
ute. The patient should be observed 
closely during the injection to make cer-
tain that respiratory or circulatory dis-
turbances do not appear before the char-
acteristic sleep of general anesthesia. 
Three to 5 minutes should elapse during 
the administration of the solution, for too 
rapid injection has been the cause of many 
of the hazards of this drug which surgeons 
complain about. 
Pupillary Reflex 
The pupillary reflex should guide the 
anesthetist in the administration of the 
drug. Dilatation of the pupil occurs first, 
followed by contraction. When the pupil 
reaches one-fourth the size of the normal 
pupil, a sufficient dose has been given. 
The onset of narcosis may be immediate 
or may take up to 30 minutes by the intra-
venous route. The intravenous method is 
now recognized as the best method and if 
done properly, anesthesia with pentobar-
bital sodium may be accomplished in all 
types of patients without danger. When 
administered per os, its action is some-
what uncertain and the dosage cannot be 
regulated as efficiently. The onset of nar-
cosis may be delayed if the stomach is 
full. As a general rule the animal recovers 
in 12 hours, but narcosis may last from 
24 to 48 hours. The dosage rate is from 8 
to 12 mg. per pound body weight when 
administered intravenously in small ani-
mals. The animal should be weighed to 
get the exact dosage. It must be increased 
or repeated in larger dogs with a higher 
metabolic rate with faster elimination of 
the drug from the body. 
The use of nembutal in large animal 
practice has been limited due to the cost 
and to the undesirable postoperative ef-
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fects of the drug, in which there is a long 
period of recovery from its effects. It has 
been used with success for general anes-
thesia in foals in doses of 5 to 25 cc., de-
pending upon the size of the foal. In calves 
and small cattle nembutal has been used 
intravenously for general anesthesia in 
doses of 50 to 125 cc. with good results. 
In mature horses excellent results have 
been obtained in using pentobarbital so-
dium as a sedative. Fifteen cc. per 1,000 
pounds body weight in large horses will 
facilitate the easy handling of the indi-
vidual in a few minutes. The amount may 
be increased for very large and nervous 
horses. The sedative dose for a horse suf-
fering from pain in the digestive tract is 
usually 15 to 25 cc. administered intra-
venously. The high cost of this drug com-
pared to choral hydrate has limited its 
usefulness in the large animal field of 
veterinary medicine. 
Amy tal and sodium amy tal are quite 
similar to nembutal in action but require 
greater dosage. Thus, their use in vet-
erinary medicine has been limited to only 
a few cases in the small animal field. 
Slow Acting Group 
The slow acting group includes barbital 
and phenobarbital, or luminal, and their 
sodium salts. These members of the bar-
biturates are indicated where a very slow 
and long-acting agent is desired. 
Barbital and barbital sodium may be 
used where prolonged effects are not a 
disadvantage. Their action is very pro-
longed and extends well into the post-
operative period, thus complicating post-
operative medication. For that reason they 
are not as extensively used for preanes-
thetic medication in surgery as the shorter 
acting members of the barbituric acid 
series. As the effects wear off, there may 
be disturbing mental complications. In 
addition, they may place undue strain on 
the heart and kidneys and so are contra-
indicated in any cardiac or renal disturb-
ance. Their use in obstetrics has not been 
very extensive probably due to their ef-
fect on the renal system already over-
burdened by pregnancy. The sodium salt 
of barbital has been used as an intra-
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muscular injection in nervous and mental 
disorders. These slower acting barbitu-
rates have a definite value in convulsive 
conditions, but the shorter acting members 
have been used in the treatment of strych-
nine convulsions and the toxemia of tet-
anus infection due to their advantage of 
immediate action. Barbital or barbital 
sodium have been used in dosages of 0.3 
to 0.6 Gm. prior to the use of either pro-
caine or cocaine in local anesthesia. The 
average dose of either of these drugs is 
0.16 to 1.0 Gm. for dogs and 0.1 to 0.25 Gm. 
in cats. They have not been used in large 
animals due to their cost and the prolonged 
postoperative effects. 
Phenobarbital and phenobarbital sodium 
or luminal are also members of the slower 
acting barbiturates. Their action is even 
more prolonged than that of barbital. Their 
suggested dosage is 0.03 to 0.2 Gm. Pheno-
barbital is especially useful in small re-
peated doses of 0.03 to 0.1 Gm. through-
out the day in preventing the occurrence 
of attacks of epilepsy. They have the same 
objections for use as preanesthetic agents 
as barbital and barbital sodium. If used 
for that purpose the average dose is 0.06 
to 0.2 Gm. Large doses of phenobarbital 
in surgical cases have resulted in collapse 
and pneumonia, due to abolition of the 
cough reflex. A failing heart, bronchitis, 
renal disease, or tuberculosis contraindi-
cate the use of phenobarbital in anesthetic 
doses. Because of these contraindications 
which are similar to those of barbital, it 
is seldom used in obstetrics. Tolerance to 
the drug has been noticed on repeated 
small doses. In dogs, not more than 0.4 
Gm. of phenobarbital should be given 
daily, and that only in divided doses of 
0.05 to 0.1 Gm. each. The dosage for cats 
is usually 0.02 to 0.015 Gm. at a single 
administration. The dosage is increased 
10 percent when the sodium salt is used. 
As with barbital, phenobarbital is seldom 
used in large animal patients for similar 
objections to cost and postoperative effects. 
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